PVP Ventures Limited has informed the Exchange about the completion of first phrase of acquisition of stake in 7Med India Private Limited ("7Med").
PVP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.2 pts less than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
PVP Ventures has completed the first phase of its acquisition of a stake in 7Med India Private Limited, a top-five player in India's dialysis services sector. With this completion, PVP now holds 14,939 equity shares, representing 33.24% of 7Med's paid-up share capital, with a binding agreement to scale up to 50.62% within twelve months. The total outlay for the full majority stake is approximately INR 127 crores, funded through a cash consideration combining primary and secondary share purchases. 7Med reported an EBITDA of around INR 10 crore for the current financial year. The deal is a pure diversification move into healthcare, as 7Med's business is outside PVP's main line, and it is not a related-party transaction.
This is a strategic diversification into the healthcare/dialysis segment and may be viewed positively by investors, though the phased acquisition and ~INR 127 crore cash outlay over 12 months could keep stock action range-bound until further milestones are met.